|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01355 BIOSYSEN
Nominal 
0.170 +0.016 (+10.390%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 25,086 | -1.411% | 51,305 | 40,684 | 67,661 | 63,002 |
| Cost of Sales | (13,446) | 59.407% | -- | -- | -- | -- |
| Gross Profit | 11,640 | -31.570% | -- | -- | -- | -- |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (2,455) | -70.564% | (10,216) | (32,832) | (43,624) | 1,422 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (1,110) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 52,726 | -- | (45,378) | (37,075) | (58,673) | (16,103) | |
| Taxation | 0 | -- | 0 | (2,685) | (3,095) | (1,544) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (31,577) | -- | 1,846 | 18,640 | 23,590 | 9,853 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 21,149 | -- | (43,532) | (21,120) | (38,178) | (7,794) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 2,039 | -20.071% | 4,898 | 5,875 | 5,787 | 7,377 |
| Depreciation & Amortisation | 5,943 | -19.318% | 13,724 | 24,026 | 29,163 | 30,649 |
| Directors' Emoluments | 338 | -2.029% | -- | 2,540 | 2,378 | 5,359 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 1.457 | -- | -3.712 | -3.078 | -5.428 | -1.110 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.034) | 0.043 | 0.078 | 0.021 |
| NBV per share ($) | (0.010) | -- | (0.024316) | (0.05021) | (0.051707) | 0.003098 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 21,149 |
| %Change | -- |
| EPS / (LPS) | HKD 0.015 |
| NBV Per Share ($) | HKD -0.010 |